Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
(NEW YORK) -- An executive for Novo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says the company is investing over $6 billion dollars to help meet the increased demand for the drugs amid ongoing shortages and high... Read More.